limonin has been researched along with Liver Diseases in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
El-Shazly, AM; Hamdan, DI; Mahmoud, MF; Wink, M | 1 |
El-Fayoumi, HM; Gamal, S; Mahmoud, MF | 1 |
2 other study(ies) available for limonin and Liver Diseases
Article | Year |
---|---|
Hepatoprotective effect of limonin, a natural limonoid from the seed of Citrus aurantium var. bigaradia, on D-galactosamine-induced liver injury in rats.
Topics: Administration, Oral; Animals; Citrus; Disease Models, Animal; Dose-Response Relationship, Drug; Galactosamine; Inflammation; Limonins; Liver Diseases; Male; Oxidative Stress; Rats; Rats, Wistar; Seeds; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2014 |
Limonin attenuates hepatocellular injury following liver ischemia and reperfusion in rats via toll-like receptor dependent pathway.
Topics: Adaptor Proteins, Vesicular Transport; Alanine Transaminase; Animals; Anti-Inflammatory Agents; Antioxidants; Aspartate Aminotransferases; Caspase 3; Cytokines; gamma-Glutamyltransferase; Glutathione Peroxidase; L-Lactate Dehydrogenase; Limonins; Liver; Liver Diseases; Male; Malondialdehyde; Myeloid Differentiation Factor 88; NF-kappa B; Rats, Wistar; Reperfusion Injury; Signal Transduction; Superoxide Dismutase; Toll-Like Receptor 2; Toll-Like Receptor 4 | 2014 |